소화관 스텐트 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

The future of the global GI stent market looks promising with opportunities in the hospital, ambulatory surgical center, and specialty clinic markets. The global GI stent market is expected to reach an estimated $958 million by 2035 with a CAGR of 5.1% from 2026 to 2035. The major drivers for this market are the increasing prevalence of gastrointestinal disorders, the rising demand for minimally invasive treatments, and the growing adoption of advanced stent technologies.

• Lucintel forecasts that, within the product type category, biliary stent is expected to witness the highest growth over the forecast period.
• Within the end use category, hospital is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the GI Stent Market

The GI stent market is experiencing rapid growth driven by technological advancements, increasing prevalence of GI disorders, and a rising aging population worldwide. As healthcare providers seek minimally invasive solutions for complex GI conditions, innovative stent designs and materials are emerging to improve patient outcomes. Additionally, regulatory approvals and expanding applications are broadening market opportunities. These developments are transforming the landscape of GI stent deployment, making treatments more effective, accessible, and tailored to patient needs. Understanding these trends is crucial for stakeholders aiming to capitalize on the evolving market dynamics and improve clinical practices.

• Technological Innovation: The development of biodegradable and drug-eluting GI stents is revolutionizing treatment options. These advanced stents reduce the need for removal procedures and help prevent restenosis, respectively. Innovations in materials and design enhance flexibility, durability, and biocompatibility, leading to better patient comfort and outcomes. As research progresses, these innovations are expected to set new standards in GI stenting, expanding their applications and improving long-term efficacy.
• Increasing Prevalence of GI Disorders: Rising incidences of conditions such as esophageal cancer, strictures, and Crohn's disease are driving demand for GI stents. The growing global burden of these diseases, especially in aging populations, necessitates minimally invasive interventions. This trend boosts market growth as healthcare providers seek effective solutions to manage complex GI conditions, leading to increased adoption of stenting procedures across hospitals and clinics.
• Expanding Applications: Initially used primarily for malignant obstructions, GI stents are now increasingly employed in benign conditions, such as strictures and fistulas. This expansion broadens the market scope and encourages innovation in stent design tailored for different indications. The ability to treat a wider range of GI disorders with minimally invasive techniques enhances patient care and reduces hospitalization times, further fueling market growth.
• Regulatory Approvals and Reimbursement Policies: Enhanced regulatory support and favorable reimbursement policies are facilitating market expansion. Approval of new stent products by agencies like the FDA and EMA ensures safety and efficacy, encouraging adoption. Additionally, insurance coverage and reimbursement schemes make procedures more accessible, driving demand. These regulatory and policy developments are crucial for market players to introduce innovative products and expand their reach.
• Rising Adoption of Minimally Invasive Procedures: The shift from traditional surgical interventions to minimally invasive endoscopic procedures is a significant trend. GI stents play a central role in this transition, offering less painful, quicker recovery options for patients. This trend is supported by technological advancements and increasing clinician expertise, leading to higher procedure volumes. The focus on patient-centered care and cost-effectiveness further accelerates the adoption of GI stenting, reshaping treatment paradigms in gastroenterology.

In summary, these trends are collectively transforming the GI stent market by fostering innovation, expanding clinical applications, and improving patient outcomes. They are driving market growth, encouraging new product development, and reshaping treatment strategies in gastrointestinal healthcare.

Recent Developments in the GI Stent Market

The GI stent market is experiencing rapid growth driven by technological advancements, increasing prevalence of gastrointestinal disorders, and expanding healthcare infrastructure worldwide. Innovations in stent design and materials are improving patient outcomes, while rising awareness and diagnosis rates are boosting demand. Additionally, strategic collaborations and regulatory approvals are facilitating market expansion. These developments are transforming the landscape, offering new opportunities for manufacturers and healthcare providers to enhance treatment options and improve patients quality of life.

• Growing Demand for Minimally Invasive Procedures: The shift towards minimally invasive treatments is fueling the GI stent market. Patients prefer less invasive options due to reduced recovery times and lower complication risks. Technological innovations have led to the development of more flexible, durable, and biocompatible stents, making procedures safer and more effective. This trend is expanding the patient base and increasing adoption rates across hospitals and clinics globally, thereby driving market growth significantly.
• Innovation in Stent Materials and Design: Advances in biomaterials and design are revolutionizing GI stents. New materials like biodegradable and drug-eluting stents are improving patient outcomes by reducing complications such as restenosis and migration. Enhanced design features, including better flexibility and radiopacity, facilitate precise placement and monitoring. These innovations are expanding indications for use, attracting more healthcare providers, and boosting market revenue through improved efficacy and safety profiles.
• Increasing Prevalence of Gastrointestinal Disorders: Rising incidences of conditions like esophageal, gastric, and colorectal cancers, as well as strictures and obstructions, are escalating the demand for GI stents. Aging populations and lifestyle factors contribute to this trend. The growing burden of these disorders necessitates effective management options, positioning GI stents as essential tools. This increasing prevalence directly correlates with higher market sales and encourages ongoing research and development in the sector.
• Strategic Collaborations and Regulatory Approvals: Partnerships between biotech firms, medical device companies, and healthcare providers are accelerating innovation and market penetration. Regulatory approvals in emerging markets are opening new avenues for sales. These collaborations facilitate the development of advanced stent technologies and streamline approval processes, ensuring faster market entry. Such strategic moves are enhancing product availability, expanding geographic reach, and strengthening the overall market position.
• Rising Adoption in Emerging Markets: Developing regions are witnessing increased adoption of GI stents due to expanding healthcare infrastructure and rising awareness. Governments and the private sector are investing in healthcare facilities, improving access to advanced treatments. Local manufacturing and cost-effective solutions are making GI stents more accessible. This growth in emerging markets is significantly contributing to global market expansion, offering new revenue streams and fostering innovation tailored to diverse patient needs.

These developments are collectively transforming the GI stent market by enhancing product innovation, expanding patient access, and improving treatment outcomes. The integration of advanced materials, strategic collaborations, and increased adoption in emerging markets are driving sustained growth. As a result, the market is becoming more competitive, diverse, and capable of meeting the evolving needs of patients worldwide, ultimately improving healthcare delivery and patient quality of life.

Strategic Growth Opportunities in the GI Stent Market

The GI stent market is experiencing significant growth driven by increasing gastrointestinal disorders, technological advancements, and rising minimally invasive procedures. The demand for innovative, durable, and biocompatible stents is expanding across hospitals, clinics, and specialized care centers worldwide. Strategic collaborations, regulatory approvals, and rising healthcare expenditure further propel market expansion. This dynamic environment offers numerous opportunities for industry players to innovate, diversify, and capture new customer segments, ultimately improving patient outcomes and healthcare efficiency.

• Growing Incidence of Gastrointestinal Diseases Presents New Market Opportunities: The rising prevalence of conditions like esophageal, biliary, and colorectal cancers, along with benign strictures, fuels demand for GI stents. As these diseases become more common globally, the need for minimally invasive, effective treatment options increases. This trend encourages manufacturers to develop specialized stents tailored to different conditions, expanding the market scope and driving innovation in product design and application.
• Technological Innovations Enhance Stent Performance and Patient Outcomes: Advances such as drug-eluting, biodegradable, and self-expanding stents improve treatment efficacy and reduce complications. Integration of imaging guidance and customization options further optimizes placement and patient comfort. These innovations attract healthcare providers seeking better clinical results, thereby expanding market adoption. Continuous R&D efforts are expected to introduce next-generation solutions, opening new avenues for growth and differentiation within the industry.
• Increasing Adoption of Minimally Invasive Procedures Promotes Market Expansion: The shift from traditional surgical interventions to endoscopic and percutaneous techniques boosts demand for GI stents. These procedures offer reduced recovery times, lower complication rates, and improved patient experiences. As healthcare providers increasingly favor minimally invasive options, the market for specialized stents grows correspondingly. This trend encourages manufacturers to develop versatile, easy-to-use products compatible with various endoscopic systems, further fueling industry growth.
• Strategic Collaborations and Regulatory Approvals Accelerate Market Penetration: Partnerships between device manufacturers, research institutions, and healthcare providers facilitate product innovation and market access. Regulatory approvals in emerging markets open new customer bases and enhance credibility. These collaborations streamline development processes and ensure compliance with safety standards, fostering confidence among clinicians and patients. As a result, the market benefits from a broader product portfolio and increased adoption, supporting sustained growth and competitive positioning.
• Rising Healthcare Expenditure and Awareness Drive Market Growth: Increasing healthcare budgets and awareness about gastrointestinal health lead to higher procedural volumes and demand for advanced stents. Governments and private insurers are investing more in minimally invasive treatments, expanding access to GI stent procedures. Educational initiatives and patient advocacy also raise awareness, encouraging early diagnosis and intervention. This environment creates favorable conditions for market expansion, innovation, and increased revenue streams for industry stakeholders.

The overall impact of these opportunities is a robust, innovative, and expanding GI stent market. As technological, clinical, and economic factors align, industry players are positioned to capitalize on emerging trends, improve patient care, and achieve sustainable growth. This evolving landscape promises continued advancements and increased accessibility, ultimately transforming gastrointestinal healthcare worldwide.

GI Stent Market Driver and Challenges

The GI stent market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in minimally invasive procedures and innovative stent designs have expanded treatment options, while the increasing prevalence of gastrointestinal disorders drives demand. Economic factors such as healthcare expenditure and insurance coverage impact accessibility and adoption. Regulatory frameworks ensure safety and efficacy but can also pose hurdles for market entry and product approval. Together, these drivers and challenges create a dynamic environment that influences market expansion, innovation, and competition, ultimately affecting patient outcomes and industry profitability.

The factors responsible for driving the GI stent market include:

• Technological Advancements: The development of innovative stent materials and designs, such as drug-eluting and biodegradable stents, has significantly improved treatment outcomes. These advancements enable minimally invasive procedures, reduce complication rates, and extend the lifespan of stents. As technology continues to evolve, clinicians can offer more effective and tailored solutions for gastrointestinal conditions, fueling market growth. The integration of imaging and navigation systems further enhances procedural precision, attracting healthcare providers to adopt these advanced options. Overall, technological progress is a key driver that sustains innovation and market expansion.
• Rising Prevalence of Gastrointestinal Disorders: Increasing incidences of conditions like esophageal strictures, tumors, and inflammatory bowel disease are driving demand for GI stents. Aging populations and lifestyle factors contribute to the rising burden of these disorders worldwide. As more patients require minimally invasive interventions, the need for effective stenting solutions grows. This trend is particularly prominent in emerging economies where healthcare infrastructure is improving. The growing patient pool directly correlates with increased market demand, encouraging manufacturers to innovate and expand their product portfolios to meet diverse clinical needs.
• Healthcare Infrastructure Development: Expansion and modernization of healthcare facilities, especially in developing regions, facilitate greater adoption of GI stenting procedures. Investments in hospitals, clinics, and specialized endoscopy centers improve access to advanced treatments. Additionally, training programs for healthcare professionals enhance procedural expertise, increasing confidence in using GI stents. This infrastructure development reduces procedural costs and improves patient outcomes, making stenting a preferred treatment option. As healthcare systems evolve, the market benefits from increased procedural volumes and broader geographic reach, supporting sustained growth.
• Increasing Healthcare Expenditure: Rising healthcare spending globally enables more patients to access advanced medical devices like GI stents. Governments and private insurers are investing in healthcare infrastructure and innovative treatments, which lower financial barriers for patients. This increased expenditure supports research and development, leading to the introduction of improved stent technologies. Moreover, higher reimbursement rates for minimally invasive procedures incentivize healthcare providers to adopt GI stents. Consequently, the market experiences growth driven by economic capacity and willingness to invest in cutting-edge gastrointestinal treatments.
• Growing Awareness and Diagnosis: Enhanced awareness about gastrointestinal diseases and improved diagnostic techniques, such as endoscopy and imaging, lead to earlier detection and intervention. Early diagnosis increases the likelihood of successful minimally invasive treatments using GI stents. Public health campaigns and medical education further promote awareness, expanding the patient base eligible for stenting procedures. This trend results in higher procedural volumes and stimulates market growth. Additionally, increased awareness encourages research and development efforts to create more effective and patient-friendly stent options, fostering innovation within the industry.

The challenges facing the GI stent market include:

• Stringent Regulatory Approvals: Navigating complex regulatory pathways for GI stents can delay product launches and increase costs. Regulatory agencies require extensive clinical data to demonstrate safety and efficacy, which can be time-consuming and expensive to obtain. Variations in approval processes across regions create additional hurdles for market entry and expansion. These regulatory challenges may hinder innovation and limit the availability of new products, impacting overall market growth. Companies must invest heavily in compliance and clinical trials, which can strain resources, especially for smaller players.
• High Cost of Advanced Stents: The development and manufacturing of innovative GI stents involve high costs, leading to higher prices for end-users. This can limit adoption in cost-sensitive markets and among healthcare providers with budget constraints. Additionally, reimbursement issues and insurance coverage limitations further restrict patient access to advanced stenting options. The high cost can also impact hospital procurement decisions, favoring more affordable alternatives. As a result, market growth may be impeded in regions where cost considerations outweigh clinical benefits, creating a barrier to widespread adoption.
• Competition and Market Saturation: The increasing number of players and product offerings intensifies competition within the GI stent market. Differentiating products becomes challenging, leading to price wars and reduced profit margins. Market saturation in developed regions may slow growth, prompting companies to seek opportunities in emerging markets. However, entering these markets involves overcoming regulatory, infrastructural, and awareness barriers. The competitive landscape necessitates continuous innovation and marketing efforts, which can strain resources and divert focus from product development, potentially hindering long-term growth prospects.

In summary, the GI stent market is shaped by rapid technological innovations, increasing disease prevalence, and expanding healthcare infrastructure, all of which promote growth. However, regulatory complexities, high costs, and intense competition pose significant challenges. These factors collectively influence market dynamics, requiring stakeholders to balance innovation with strategic planning. Overall, the markets future depends on how effectively companies can navigate these drivers and challenges to deliver safe, affordable, and innovative solutions that meet evolving clinical needs.

List of GI Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies GI stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the GI stent companies profiled in this report include-

• Boston Scientific Corporation
• Cook Medical
• C.R. Bard, Inc.
• ELLA-CS, s.r.o.
• Taewoong Medical Co., Ltd.
• Olympus Corporation
• Becton, Dickinson and Company
• Merit Medical Systems, Inc.
• M.I. Tech Co., Ltd.
• ConMed Corporation

GI Stent Market by Segment

The study includes a forecast for the global GI stent market by product type, material, end use, and region.

GI Stent Market by Product Type [Value from 2019 to 2035]:

• Biliary Stents
• Esophageal Stents
• Duodenal Stents
• Colonic Stents

GI Stent Market by Material [Value from 2019 to 2035]:

• Metal Stents
• Plastic Stents

GI Stent Market by End Use [Value from 2019 to 2035]:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

GI Stent Market by Region [Value from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the GI Stent Market

The GI stent market has experienced significant advancements driven by technological innovations, increasing prevalence of gastrointestinal disorders, and expanding healthcare infrastructure worldwide. As countries adopt new medical technologies and improve patient care, the market dynamics are shifting, with notable growth in developed and developing regions. Regulatory approvals, research developments, and rising awareness about minimally invasive procedures are also influencing market trends. These developments reflect a broader trend toward improved treatment options and personalized healthcare solutions for gastrointestinal conditions, impacting the global landscape of GI stent utilization and innovation.

• United States: The US market has seen rapid adoption of advanced GI stents with innovations such as drug-eluting and biodegradable options. Increased investment in research and development, along with favorable reimbursement policies, has driven growth. The rising prevalence of gastrointestinal cancers and strict regulatory standards have further propelled market expansion. Additionally, the integration of minimally invasive procedures and technological improvements in stent design have enhanced patient outcomes and procedural success rates.
• China: China's GI stent market is experiencing robust growth due to increasing healthcare infrastructure and rising awareness of gastrointestinal diseases. The government's focus on healthcare reforms and expanding insurance coverage has improved access to advanced treatments. Local manufacturers are gaining market share by offering cost-effective, innovative stents, including biodegradable and self-expanding variants. The growing prevalence of gastrointestinal disorders, coupled with a rising geriatric population, is fueling demand for minimally invasive solutions.
• Germany: Germany's market benefits from a well-established healthcare system and high adoption of innovative medical devices. The focus on quality and safety standards has led to the approval of advanced GI stents, including those with anti-migration features. Increasing prevalence of gastrointestinal conditions and a strong emphasis on research and clinical trials are driving market growth. Moreover, collaborations between healthcare providers and device manufacturers are fostering innovation and expanding the availability of specialized stents.
• India: The Indian GI stent market is expanding rapidly due to increasing cases of gastrointestinal cancers and disorders. Rising healthcare awareness, improved infrastructure, and government initiatives to promote affordable healthcare are key factors. Local manufacturers are introducing cost-effective, innovative stents to meet the growing demand. The adoption of minimally invasive procedures and the increasing number of hospitals equipped with advanced endoscopy facilities are further boosting market growth.
• Japan: Japan's market is characterized by high technological adoption and a focus on minimally invasive treatments. The aging population has led to increased cases of gastrointestinal diseases, driving demand for advanced stents. Japan's stringent regulatory environment ensures high-quality standards, fostering innovation in biodegradable and drug-eluting stents. Collaborations between research institutions and industry players are accelerating the development of next-generation GI stents, with a focus on improving patient comfort and treatment efficacy.

Features of the Global GI Stent Market

• Market Size Estimates: GI stent market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: GI stent market size by product type, material, end use, and region in terms of value ($M).
• Regional Analysis: GI stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, materials, end uses, and regions for the GI stent market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the GI stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the GI stent market by product type (biliary stents, esophageal stents, duodenal stents, and colonic stents), material (metal stents and plastic stents), end use (hospitals, ambulatory surgical centers, and specialty clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global GI Stent Market by Product Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Product Type
• 4.3 Biliary Stents : Trends and Forecast (2019-2035)
• 4.4 Esophageal Stents : Trends and Forecast (2019-2035)
• 4.5 Duodenal Stents : Trends and Forecast (2019-2035)
• 4.6 Colonic Stents : Trends and Forecast (2019-2035)

5. Global GI Stent Market by Material

• 5.1 Overview
• 5.2 Attractiveness Analysis by Material
• 5.3 Metal Stents : Trends and Forecast (2019-2035)
• 5.4 Plastic Stents : Trends and Forecast (2019-2035)

6. Global GI Stent Market by End Use

• 6.1 Overview
• 6.2 Attractiveness Analysis by End Use
• 6.3 Hospitals : Trends and Forecast (2019-2035)
• 6.4 Ambulatory Surgical Centers : Trends and Forecast (2019-2035)
• 6.5 Specialty Clinics : Trends and Forecast (2019-2035)

7. Regional Analysis

• 7.1 Overview
• 7.2 Global GI Stent Market by Region

8. North American GI Stent Market

• 8.1 Overview
• 8.2 North American GI Stent Market by Product Type
• 8.3 North American GI Stent Market by End Use
• 8.4 The United States GI Stent Market
• 8.5 Canadian GI Stent Market
• 8.6 Mexican GI Stent Market

9. European GI Stent Market

• 9.1 Overview
• 9.2 European GI Stent Market by Product Type
• 9.3 European GI Stent Market by End Use
• 9.4 German GI Stent Market
• 9.5 French GI Stent Market
• 9.6 Italian GI Stent Market
• 9.7 Spanish GI Stent Market
• 9.8 The United Kingdom GI Stent Market

10. APAC GI Stent Market

• 10.1 Overview
• 10.2 APAC GI Stent Market by Product Type
• 10.3 APAC GI Stent Market by End Use
• 10.4 Chinese GI Stent Market
• 10.5 Indian GI Stent Market
• 10.6 Japanese GI Stent Market
• 10.7 South Korean GI Stent Market
• 10.8 Indonesian GI Stent Market

11. ROW GI Stent Market

• 11.1 Overview
• 11.2 ROW GI Stent Market by Product Type
• 11.3 ROW GI Stent Market by End Use
• 11.4 Middle Eastern GI Stent Market
• 11.5 South American GI Stent Market
• 11.6 African GI Stent Market

12. Competitor Analysis

• 12.1 Product Portfolio Analysis
• 12.2 Operational Integration
• 12.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

• 13.1 Value Chain Analysis
• 13.2 Growth Opportunity Analysis
  • 13.2.1 Growth Opportunity by Product Type
  • 13.2.2 Growth Opportunity by Material
  • 13.2.3 Growth Opportunity by End Use
• 13.3 Emerging Trends in the Global GI Stent Market
• 13.4 Strategic Analysis
  • 13.4.1 New Product Development
  • 13.4.2 Certification and Licensing
  • 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

• 14.1 Competitive Analysis Overview
• 14.2 Boston Scientific Corporation
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.3 Cook Medical
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.4 C.R. Bard, Inc.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.5 ELLA-CS, s.r.o.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.6 Taewoong Medical Co., Ltd.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.7 Olympus Corporation
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.8 Becton, Dickinson and Company
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.9 Merit Medical Systems, Inc.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.10 M.I. Tech Co., Ltd.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.11 ConMed Corporation
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

15. Appendix

• 15.1 List of Figures
• 15.2 List of Tables
• 15.3 Research Methodology
• 15.4 Disclaimer
• 15.5 Copyright
• 15.6 Abbreviations and Technical Units
• 15.7 About Us
• 15.8 Contact Us